Literature DB >> 6751268

Radical pelvic surgery versus radical surgery plus radiotherapy for stage Ib carcinoma of the cervix uteri. Preliminary results of a prospective randomized clinical study.

K Bilek, K Ebeling, H Leitsmann, G Seidel.   

Abstract

In a preliminary report of a prospective controlled study treatment results and therapy morbidity of 60 patients with stage pT1bNoMo carcinoma of the uterine cervix treated by radical surgery only (Wertheim-Meigs) were compared with those of 60 patients treated by radical surgery followed by a postoperative external radiotherapy. The median duration of follow-up was 44 (24--72) months. Comparing the survival probability analyzed by life-table-method up to 18 months there was a significant better result for patients treated with surgery only. However, after that the study demonstrated comparable therapeutic results with the two therapeutic regimens. There was no difference of tumor size in patients who died after surgery alone and those who died after combined therapy. The therapy morbidity was slightly greater in patients treated by combined therapy. Especially lymphedemas of the leg developed more frequent in patients treated with combined surgery and radiotherapy. Preliminary analysis of the study does not demonstrate any beneficial effect of postoperative radiotherapy followed a radical hysterectomy with pelvic lymphonodectomy in cervical cancer stage pT1bNoMo, but optimal staging, radical surgery and carefully histological examination of the removed tissue are essential needs for this approach.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751268

Source DB:  PubMed          Journal:  Arch Geschwulstforsch        ISSN: 0003-911X


  6 in total

Review 1.  Radiotherapy and chemoradiation after surgery for early cervical cancer.

Authors:  Linda Rogers; Shing Shun N Siu; David Luesley; Andrew Bryant; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  Recent progress in the treatment and prevention of cancer-related lymphedema.

Authors:  Simona F Shaitelman; Kate D Cromwell; John C Rasmussen; Nicole L Stout; Jane M Armer; Bonnie B Lasinski; Janice N Cormier
Journal:  CA Cancer J Clin       Date:  2014-11-19       Impact factor: 508.702

Review 3.  Adjuvant therapy in early-stage cervical cancer after radical hysterectomy: are we overtreating our patients? A meta-analysis.

Authors:  Natalia R Gómez-Hidalgo; Úrsula Acosta; Tomás Gómez Rodríguez; Soraya Mico; Ramona Verges; Vicente Bebia Conesa; Melissa Bradbury; Santiago Pérez-Hoyos; Asunción Pérez-Benavente; Antonio Gil-Moreno
Journal:  Clin Transl Oncol       Date:  2022-04-19       Impact factor: 3.340

Review 4.  Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature.

Authors:  David Cibula; Nadeem R Abu-Rustum; Daniela Fischerova; Selvan Pather; Katie Lavigne; Jiri Slama; Kaled Alektiar; Lin Ming-Yin; Roman Kocian; Anna Germanova; Filip Frühauf; Lukas Dostalek; Ladislav Dusek; Kailash Narayan
Journal:  Gynecol Oncol       Date:  2018-10-20       Impact factor: 5.482

5.  Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).

Authors:  Kazuto Nakamura; Yoshikazu Kitahara; Toyomi Satoh; Yuji Takei; Masashi Takano; Shoji Nagao; Isao Sekiguchi; Mitsuaki Suzuki
Journal:  World J Surg Oncol       Date:  2016-06-29       Impact factor: 2.754

6.  Risks and Benefits of Multimodal Esophageal Cancer Treatments: A Meta-Analysis.

Authors:  Lei Sun; Fen Zhao; Yan Zeng; Cheng Yi
Journal:  Med Sci Monit       Date:  2017-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.